Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Statin Intolerance Clinical Guide 2018.
Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R, Hirata A; Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics. Kajinami K, et al. Among authors: yamashita s. J Atheroscler Thromb. 2020 Apr 1;27(4):375-396. doi: 10.5551/jat.50948. Epub 2019 Oct 4. J Atheroscler Thromb. 2020. PMID: 31588101 Free PMC article. No abstract available.
Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--.
Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T; Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan. Maruyama T, et al. Among authors: yamashita s. J Atheroscler Thromb. 2004;11(3):131-45. doi: 10.5551/jat.11.131. J Atheroscler Thromb. 2004. PMID: 15256764 Free article.
Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice.
Sandoval JC, Nakagawa-Toyama Y, Masuda D, Tochino Y, Nakaoka H, Kawase R, Yuasa-Kawase M, Nakatani K, Inagaki M, Tsubakio-Yamamoto K, Ohama T, Nishida M, Ishigami M, Komuro I, Yamashita S. Sandoval JC, et al. Among authors: yamashita s. J Atheroscler Thromb. 2010 Jun 30;17(6):610-8. doi: 10.5551/jat.3988. Epub 2010 Mar 30. J Atheroscler Thromb. 2010. PMID: 20351468 Free article.
Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases.
Yuasa-Kawase M, Masuda D, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Nakatani K, Tsubakio-Yamamoto K, Ohama T, Matsuyama A, Nishida M, Ishigami M, Kawamoto T, Komuro I, Yamashita S. Yuasa-Kawase M, et al. Among authors: yamashita s, yamashita t. J Atheroscler Thromb. 2012;19(3):263-75. doi: 10.5551/jat.10603. Epub 2011 Nov 10. J Atheroscler Thromb. 2012. PMID: 22075538 Free article.
Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.
Inagaki M, Nakagawa-Toyama Y, Nishida M, Nakatani K, Nakaoka H, Kawase M, Kawase R, Tsubakio-Yamamoto K, Masuda D, Ohama T, Matsuyama A, Ishigami M, Komuro I, Yamashita S. Inagaki M, et al. Among authors: yamashita s. J Atheroscler Thromb. 2012;19(7):643-56. doi: 10.5551/jat.12807. Epub 2012 Jul 5. J Atheroscler Thromb. 2012. PMID: 22785024 Free article.
Apolipoprotein B-48 to triglyceride ratio is a novel and useful marker for detection of type III hyperlipidemia after antihyperlipidemic intervention.
Yuasa-Kawase M, Masuda D, Kitazume-Taneike R, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Nakatani K, Tsubakio-Yamamoto K, Ohama T, Toyama-Nakagawa Y, Nishida M, Ishigami M, Saito M, Eto M, Matsuyama A, Komuro I, Yamashita S. Yuasa-Kawase M, et al. Among authors: yamashita s, yamashita t. J Atheroscler Thromb. 2012;19(9):862-71. doi: 10.5551/jat.13052. Epub 2012 Aug 9. J Atheroscler Thromb. 2012. PMID: 22878701 Free article.
4,363 results